The results showed that INHBA mRNA expression was upregulated in bladder, breast, cervical, colorectal, esophageal, gastric, head and neck, ovarian, and pancreatic cancers and sarcoma with respect to normal tissues, whereas INHBA was downregulated in kidney cancer, leukemia, and melanoma. Here, INHBA is linked to leukemia.